411 related articles for article (PubMed ID: 16299553)
1. The immunomodulator FTY720 and its phosphorylated derivative activate the Smad signalling cascade and upregulate connective tissue growth factor and collagen type IV expression in renal mesangial cells.
Xin C; Ren S; Eberhardt W; Pfeilschifter J; Huwiler A
Br J Pharmacol; 2006 Jan; 147(2):164-74. PubMed ID: 16299553
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine 1-phosphate cross-activates the Smad signaling cascade and mimics transforming growth factor-beta-induced cell responses.
Xin C; Ren S; Kleuser B; Shabahang S; Eberhardt W; Radeke H; Schäfer-Korting M; Pfeilschifter J; Huwiler A
J Biol Chem; 2004 Aug; 279(34):35255-62. PubMed ID: 15192102
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3.
Yang F; Chung AC; Huang XR; Lan HY
Hypertension; 2009 Oct; 54(4):877-84. PubMed ID: 19667256
[TBL] [Abstract][Full Text] [Related]
4. [FTY720 attenuates rat anti-Thy-1 mesangial proliferative glomerulonephritis by inhibition of transforming growth factor β1-connective tissue growth factor pathway].
Jiang JY; Huang XD; Wang Y; Deng AP; Zhou JH
Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):107-11. PubMed ID: 22455887
[TBL] [Abstract][Full Text] [Related]
5. Icariin attenuates high glucose-induced type IV collagen and fibronectin accumulation in glomerular mesangial cells by inhibiting transforming growth factor-β production and signalling through G protein-coupled oestrogen receptor 1.
Li YC; Ding XS; Li HM; Zhang C
Clin Exp Pharmacol Physiol; 2013 Sep; 40(9):635-43. PubMed ID: 23772748
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways.
Pannu J; Nakerakanti S; Smith E; ten Dijke P; Trojanowska M
J Biol Chem; 2007 Apr; 282(14):10405-13. PubMed ID: 17317656
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms through which bradykinin promotes glomerular injury in diabetes.
Tan Y; Wang B; Keum JS; Jaffa AA
Am J Physiol Renal Physiol; 2005 Mar; 288(3):F483-92. PubMed ID: 15692059
[TBL] [Abstract][Full Text] [Related]
8. CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC.
Chen Y; Blom IE; Sa S; Goldschmeding R; Abraham DJ; Leask A
Kidney Int; 2002 Oct; 62(4):1149-59. PubMed ID: 12234285
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulator FTY720 induces myofibroblast differentiation via the lysophospholipid receptor S1P3 and Smad3 signaling.
Keller CD; Rivera Gil P; Tölle M; van der Giet M; Chun J; Radeke HH; Schäfer-Korting M; Kleuser B
Am J Pathol; 2007 Jan; 170(1):281-92. PubMed ID: 17200201
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism.
Rodríguez-Vita J; Sánchez-López E; Esteban V; Rupérez M; Egido J; Ruiz-Ortega M
Circulation; 2005 May; 111(19):2509-17. PubMed ID: 15883213
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of sphingosine 1-phosphate receptor agonist in human endothelial cells.
Butler J; Lana D; Round O; LaMontagne K
Prostaglandins Other Lipid Mediat; 2004 Jan; 73(1-2):29-45. PubMed ID: 15165029
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the TGFbeta/Smad signaling pathway in mesangial cells by CTGF/CCN2.
Wahab NA; Weston BS; Mason RM
Exp Cell Res; 2005 Jul; 307(2):305-14. PubMed ID: 15950619
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signaling.
Sobel K; Menyhart K; Killer N; Renault B; Bauer Y; Studer R; Steiner B; Bolli MH; Nayler O; Gatfield J
J Biol Chem; 2013 May; 288(21):14839-51. PubMed ID: 23589284
[TBL] [Abstract][Full Text] [Related]
14. Effects of phosphorylation of immunomodulatory agent FTY720 (fingolimod) on antiproliferative activity against breast and colon cancer cells.
Nagaoka Y; Otsuki K; Fujita T; Uesato S
Biol Pharm Bull; 2008 Jun; 31(6):1177-81. PubMed ID: 18520051
[TBL] [Abstract][Full Text] [Related]
15. FTY720 suppresses interleukin-1beta-induced secretory phospholipase A2 expression in renal mesangial cells by a transcriptional mechanism.
Xin C; Ren S; Eberhardt W; Pfeilschifter J; Huwiler A
Br J Pharmacol; 2007 Apr; 150(7):943-50. PubMed ID: 17325654
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of connective tissue growth factor by sphingosine 1-phosphate in rat cultured mesangial cells.
Katsuma S; Ruike Y; Yano T; Kimura M; Hirasawa A; Tsujimoto G
FEBS Lett; 2005 May; 579(12):2576-82. PubMed ID: 15862293
[TBL] [Abstract][Full Text] [Related]
17. Evidence for low-density lipoprotein-induced expression of connective tissue growth factor in mesangial cells.
Sohn M; Tan Y; Klein RL; Jaffa AA
Kidney Int; 2005 Apr; 67(4):1286-96. PubMed ID: 15780081
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability.
Sanchez T; Estrada-Hernandez T; Paik JH; Wu MT; Venkataraman K; Brinkmann V; Claffey K; Hla T
J Biol Chem; 2003 Nov; 278(47):47281-90. PubMed ID: 12954648
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta1-induced connective tissue growth factor (CCN2) expression in human renal proximal tubule epithelial cells requires Ras/MEK/ERK and Smad signalling.
Phanish MK; Wahab NA; Hendry BM; Dockrell ME
Nephron Exp Nephrol; 2005; 100(4):e156-65. PubMed ID: 15855807
[TBL] [Abstract][Full Text] [Related]
20. Heterologous desensitization of the sphingosine-1-phosphate receptors by purinoceptor activation in renal mesangial cells.
Xin C; Ren S; Pfeilschifter J; Huwiler A
Br J Pharmacol; 2004 Nov; 143(5):581-9. PubMed ID: 15466446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
